News

A group of researchers, including those from the National Institutes of Health, discovered "rogue antibodies" that correspond with severe disease...

It's no secret that pharmaceutical companies have been criticised for their unequal access to COVID-19 vaccines. Oxfam has won several battles...

Singapore is the first country in WHO's categorization of regulatory authority for medical goods to obtain the highest maturity level...

In the fight against COVID-19, the world may soon have another vaccine choice. A positive result from late-stage clinical testing...

On the opening day of the 19th edition of BioAsia, a special fireside chat between Dr. Sangita Reddy, MD, of...

WHO along with its academy and the Republic of Korea, have announced the inception of a global bio manufacturing training...

Earlier in February this year, Novartis, which happens to be a Swiss drug major, sold its three rooted brands to...

Recipharm, the Swedish CDMO, which happens to be Moderna’s COVID-19 vaccine production partner, has undergone not one but two acquisitions...

Xanadu Bio, in association with Yale University, has come up with a nanoparticle delivery platform that will help to position...